Stepan Company (NYSE:SCL) reported first-quarter 2026 financial results on Tuesday, April 28, 2026, highlighting a period of aggressive internal realignment.
The specialty and intermediate chemical manufacturer posted a net loss of $41.4 million for the quarter, a figure heavily impacted by a $65.4 million pre-tax restructuring charge as the company seeks to streamline its global operations and cost structure.
On an adjusted basis, Stepan reported net income of $10.3 million.
Consolidated adjusted EBITDA reached $49.6 million, representing a 14% decrease compared to the first quarter of 2025.
The decline in profitability was attributed to flat organic volumes and a challenging margin environment in certain polymer segments, which offset a 4% rise in organic net sales.
In a move to strengthen its balance sheet and unlock capital, Stepan announced it has entered into an agreement to sell a portion of its land for $30 million.
The proceeds from this divestiture are expected to bolster liquidity as the company navigates a period of negative free cash flow, which stood at $(14) million for the quarter, primarily due to the timing of capital expenditures and working capital requirements.
Meanwhile, the company’s Surfactant segment continues to face a mixed demand environment, while the Polymers business is adjusting to shifting dynamics in the construction and insulation markets.